Friday, June 13, 2025
CN
  • About
  • Advertise
  • Careers
  • Contact
Money Compass
  • Home
  • Financial News
  • Investment News
  • Other News
    • Bursa News
    • Government News
    • Listing Companies News
    • Oversea Financial & Investment News
  • Interviews
    • Features Interviews
    • Corporate Interviews
  • Financial & Investment Articles
  • PR Newswire
  • Login
No Result
View All Result
Money Compass
Home PR Newswire

LabConnect Selects Deloitte to Streamline Financial and Business Operations

Money Compass by Money Compass
June 12, 2025
in PR Newswire
0
LabConnect Selects Deloitte to Streamline Financial and Business Operations
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

JOHNSON CITY, Tenn., June 13, 2025 /PRNewswire/ — LabConnect, a leading provider of global central laboratory and support services for clinical trials, has selected Microsoft Dynamics 365 Finance and Supply Chain, and also engaged Deloitte to transform its enterprise resource planning (ERP) platform. This initiative is designed to streamline LabConnect’s financial and business operations while enhancing financial reporting management in line with the company’s long-term growth strategy.

LabConnect Logo

This project marks a significant step forward in LabConnect’s plan to modernize workflows and reduce reliance on manual processes. By automating key financial and operational functions, LabConnect will increase efficiency and position itself for rapid global scaling.

Related posts

NYSE Content Advisory: Pre-Market update + Wall Street responds to geopolitical events

NYSE Content Advisory: Pre-Market update + Wall Street responds to geopolitical events

June 13, 2025
SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging

SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging

June 13, 2025

“As we continue to expand our global footprint, this ERP modernization will enable LabConnect to better serve our clients with more responsive and efficient solutions,” said David Rynders, Vice President, Global Corporate Controller. “LabConnect’s partnership with Deloitte for the implementation of Microsoft Dynamics 365 Finance and Supply Chain strengthens our ability to deliver seamless, efficient, and scalable solutions to our customers around the world. By leveraging Deloitte’s global expertise and industry-leading solutions, we ensure faster, more streamlined operations that enhance service reliability and responsiveness.”

The upgraded ERP system will also deliver significant value and efficiency for LabConnect’s clients.

  • Enhanced automation in finance and supply chain processes will accelerate invoicing, improve kit turnaround times, and increase accuracy across procurement and manufacturing.
  • Advanced Materials Requirements Planning (MRP) capabilities will strengthen the company’s ability to source unique products efficiently, improving trial support logistics.
  • Integrated data systems will deliver more accurate and timely reporting and better visibility into shipping and material tracking.

This transformation reinforces LabConnect’s strategic commitment to operational excellence and positions the company to meet the evolving needs of the global clinical trial landscape.

About LabConnect
LabConnect is the world’s most agile central laboratory solutions partner, providing technology-driven, customized, orchestrated, and scalable support services for clinical trials of all sizes and complexity. With over 20 years experience and 2,000+ clinical studies across 93 countries, LabConnect is the trusted partner for biotechnology, pharmaceutical, and clinical research organizations.

With modern operations and strategic alliances with world-leading laboratories, LabConnect is uniquely positioned to provide access to the latest innovation and automation. LabConnect delivers exceptional service with a comprehensive suite of central laboratory solutions including custom lab kits, advanced sample tracking and integrated logistics, global standardized sample processing, industry-leading testing menu of 20,000+ validated assays, worldwide support for radiopharmaceuticals, and next-generation biorepository.

LabConnect scientific experts support pre-clinical and clinical studies with scientific project management, bioanalytical and biospecimen management, biomarker strategy and logistics solutions. LabConnect excels at data management, integrating complex datasets from diverse sources into a single, cohesive, submission-ready dataset.

Follow LabConnect on LinkedIn
Learn more at www.labconnect.com

Logo – https://mma.prnewswire.com/media/2611513/LabConnect_Logo.jpg

Cision View original content:https://www.prnewswire.com/apac/news-releases/labconnect-selects-deloitte-to-streamline-financial-and-business-operations-302480437.html

SOURCE LabConnect

​ 

Previous Post

Dazu Rock Carvings: The Last Monument of World Grotto Art

Next Post

The MWCapital Awards recognise the international tech projects with the greatest impact on sustainability

Next Post
The MWCapital Awards recognise the international tech projects with the greatest impact on sustainability

The MWCapital Awards recognise the international tech projects with the greatest impact on sustainability

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire

BROWSE BY TOPICS

2018 League Balinese Culture Bali United Budget Travel business Champions League Chopper Bike Doctor Terawan industrial Istana Negara Malaysia Market Stories National Exam net zero emissions targets 2025 Renewable energy Visit Bali

Recent News

  • NYSE Content Advisory: Pre-Market update + Wall Street responds to geopolitical events
  • SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging
  • Neurophet Participates in BIO USA 2025: To showcase Brain Imaging Analysis Solutions Including ‘Neurophet AQUA AD’

Category

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire
  • About
  • Advertise
  • Careers
  • Contact

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Features Interviews
  • Government News
  • Financial News
  • Investment News
  • Listing Companies News
  • Corporate Interviews
  • Bursa News
  • Financial & Investment Articles
  • Oversea Financial & Investment News

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved